Pharmacology, Toxicology and Pharmaceutical Science
Low Density Lipoprotein Cholesterol
100%
Familial Hypercholesterolemia
86%
Statin (Protein)
79%
Placebo
51%
High Density Lipoprotein Cholesterol
46%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
39%
Coronary Artery Disease
36%
Atorvastatin
35%
Cardiovascular Risk
31%
Triacylglycerol
30%
Lipoprotein
30%
Atherosclerosis
29%
Ischemic Heart Disease
28%
Cholesterol Ester Transfer Protein
23%
Dyslipidemia
23%
Biochemistry, Genetics and Molecular Biology
Familial Hypercholesterolemia
72%
Low-Density Lipoprotein
38%
HDL-Cholesterol
36%
Statin
32%
Lipid
31%
Apolipoprotein B
21%
Lipoprotein
21%
LDL Receptor
20%
High-Density Lipoprotein
19%
Low Density Lipoprotein Cholesterol Level
18%
Triglyceride
18%
Blood Plasma
18%
Cholesteryl Ester
17%
Diacylglycerol Lipase
17%
High Density Lipoprotein Cholesterol Level
16%
Keyphrases
Homozygous Familial Hypercholesterolemia (HoFH)
49%
Low-density Lipoprotein Cholesterol (LDL-C)
32%
Statins
21%
Cardiovascular Risk
18%
Placebo
15%
High-density Lipoprotein Cholesterol (HDL-C)
15%
Lipoproteins
14%
Statin Therapy
13%
Low-density Lipoprotein Cholesterol Level
13%
LDL Cholesterol
12%
Apolipoprotein B (Apo B)
12%
Atorvastatin
12%
Cardiovascular Disease
11%
Cholesterol Absorption Inhibitor
11%
Coronary Artery Disease
10%
